Bristol-Myers Squibb Holdings Limited

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 52 3000
Fax: +44 (0)1895 52 3010
Medical Information Direct Line: +1 800 749 749
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Patient Information Leaflet last updated on the eMC: 24/11/2011
PIL Megace 160 mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
Updated on 02/06/2011 and displayed until 24/11/2011
Reasons for adding or updating:
  • Change of manufacturer
Updated on 08/12/2010 and displayed until 02/06/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change due to user-testing of patient information
Updated on 22/01/2010 and displayed until 08/12/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 25/07/2008 and displayed until 22/01/2010
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 05/05/2006 and displayed until 25/07/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   megestrol acetate